PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23726675-1	2013	Naloxegol (previously known as NKTR-118) is a peripherally acting mu-opioid receptor antagonist engineered using polymer conjugate technology in development as an oral, once-daily agent for the treatment of opioid-induced constipation (OIC).	naloxegol	0-9	natural killer cell triggering receptor	Homo sapiens	31-35